Castle biosciences presents clinical use scenarios for its diagnostic gene expression profile tests at maui derm np+pa fall 2022 conference

Friendswood, texas--(business wire)---- $cstl #cstl--castle provided a proposed framework for use of its mypath® melanoma and diffdx®-melanoma tests to help achieve personalized management plans.
CSTL Ratings Summary
CSTL Quant Ranking